Rhinomed Limited's market cap is currently ―. The company's EPS TTM is $-0.025; its P/E ratio is -0.54; Rhinomed Limited is scheduled to report earnings on February 27, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 1.98M	AU$ 2.34M	AU$ 7.76M	AU$ 1.42M	AU$ 1.26M
Total Assets	AU$ 8.50M	AU$ 6.55M	AU$ 12.81M	AU$ 5.87M	AU$ 5.91M
Total Debt	AU$ 336.74K	AU$ 470.46K	AU$ 588.15K	AU$ 0.00	AU$ 0.00
Net Debt	AU$ -1.65M	AU$ -1.87M	AU$ -7.17M	AU$ -1.42M	AU$ -1.26M
Total Liabilities	AU$ 3.46M	AU$ 1.78M	AU$ 1.96M	AU$ 1.25M	AU$ 1.14M
Stockholders Equity	AU$ 5.03M	AU$ 4.76M	AU$ 10.86M	AU$ 4.62M	AU$ 4.77M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Rhinomed Limited Earnings and Revenue History

Income Statement >

Rhinomed Limited Debt to Assets

Balance Sheet >

Rhinomed Limited Cash Flow

Cash Flow >

Rhinomed Limited Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing